Cite
HARVARD Citation
Petrylak, D. et al. (n.d.). 2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma. European journal of cancer. pp. S476-. [Online].